Fresh off cor­po­rate split, blue­bird bio plots new hy­brid head­quar­ters at Somerville's As­sem­bly Row

Re­coup­ing from a se­ries of set­backs for its gene ther­a­py busi­ness, blue­bird bio suc­cess­ful­ly bi­sect­ed it­self ear­li­er this week as part of a big re­brand around ge­net­ic dis­ease. Now, with its fu­ture still in the wind, blue­bird has found a new nest.

Blue­bird has signed a lease for a new 61,000 square-foot head­quar­ters at As­sem­bly Row in Somerville, MA, that the new­ly stripped-down biotech en­vi­sions as its hy­brid home base of the fu­ture af­ter spin­ning off its on­col­o­gy busi­ness ear­li­er this week.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER